Remacemide: current status and clinical applications-Reference-Cited by-同舟云学术

Remacemide: current status and clinical applications

Published:2000-04 Issue:4 Volume:9 Page:871-833
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Schachter Steven C¹,Tarsy Daniel¹

Affiliation:

1. Departments of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, K-478, Boston, MA 02215, USA. sschacht@caregroup.harvard.edu

Publisher

Informa Healthcare

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1517/13543784.9.4.871

Reference75 articles.

1. Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders

2. Exitatory Amino Acids in Health and Disease

3. Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines

4. Excitatory amino acids in epilepsy and potential novel therapies

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GluN2B subunit selective N-methyl-D-aspartate receptor ligands: Democratizing recent progress to assist the development of novel neurotherapeutics;Molecular Diversity;2023-06-02

2. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review;Medicinal Research Reviews;2017-07-11

3. Remacemide;Meyler's Side Effects of Drugs;2016

4. Pharmacologically Active Drug Metabolites: Impact on Drug Discovery and Pharmacotherapy;Pharmacological Reviews;2013-02-13

5. The mechanisms of brain ischemic insult and potential protective interventions;Neuroscience Bulletin;2009-06